Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107402
Filing Date
2025-11-06
Accepted
2025-11-06 07:46:04
Documents
64
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20250930x10q.htm   iXBRL 10-Q 1510465
2 EX-31.1 cgtx-20250930xex31d1.htm EX-31.1 16608
3 EX-31.2 cgtx-20250930xex31d2.htm EX-31.2 16897
4 EX-32.1 cgtx-20250930xex32d1.htm EX-32.1 9967
5 EX-32.2 cgtx-20250930xex32d2.htm EX-32.2 10140
  Complete submission text file 0001104659-25-107402.txt   6294685

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20250930.xsd EX-101.SCH 42870
7 EX-101.CAL cgtx-20250930_cal.xml EX-101.CAL 45198
8 EX-101.DEF cgtx-20250930_def.xml EX-101.DEF 148344
9 EX-101.LAB cgtx-20250930_lab.xml EX-101.LAB 405494
10 EX-101.PRE cgtx-20250930_pre.xml EX-101.PRE 296197
67 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20250930x10q_htm.xml XML 986908
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2500 WESTCHESTER AVE PURCHASE NY 10577 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 251456220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)